Company Data
MiNK Therapeutics Inc.
Ticker
INKT
Current Price
$14.82 -7.26%
Market Cap
$67.0M
Price Target
Refer to Report
Volume
40.0K
52wk Range
$4.5601 - $76
Overview
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.